Vaginal progesterone during the first trimester of pregnancy in women with unexplained recurrent miscarriages did not increase the rate of live births or improve newborn survival, according to a new ... Wayne State University - Office of the Vice President for Research Treatment with vaginal progesterone reduced the risk of preterm birth, neonatal complications and death in pregnant women with twins ... โ€” Women with a sonographically detected short cervix cut their risk for preterm birth in half with vaginal progesterone, according to a meta-analysis published online December 14 in ...

Understanding the Context

Treatment with vaginal progesterone may help reduce certain risks that can occur when mothers are pregnant with twins and have a short cervix, which is a risk factor for preterm birth. The findings ... FierceBiotech: FDA Advisory Committee declines to approve Progesterone Vaginal Gel 8% to reduce risk of Preterm Birth FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - Preterm birth is a ... FDA Advisory Committee declines to approve Progesterone Vaginal Gel 8% to reduce risk of Preterm Birth A new study provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

Key Insights

A ... News Medical: Vaginal progesterone may not be effective for preventing preterm births Vaginal progesterone, a hormone treatment considered the standard of care for preventing preterm birth in at-risk pregnant women, may not be effective, according to UT Southwestern Medical Center ... FierceBiotech: FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth